American Century Companies’s ArriVent BioPharma AVBP Stock Holding History
Bought
Maintained
Sold
Other funds holding AVBP
SCM
IAM
HA
O
OCA
SI
American Century Companies's AVBP Position: Q2 2026 in Review
American Century Companies increased its ArriVent BioPharma (AVBP) stake by 0.1% in Q2 2026, buying an estimated $561 and bringing the position to 19,534 shares worth $679K. The position accounts for ﹤0.01% of the portfolio, ranked #2515.
American Century Companies first reported a position in AVBP in Q1 2026 and has held it in 2 quarters since. 157 funds tracked by Wall St. Rank hold AVBP as of Q2 2026.
- American Century Companies held 19,534 shares of ArriVent BioPharma worth $679K as of Q2 2026.
- American Century Companies bought 19 ArriVent BioPharma shares in Q2 2026, an estimated $561.
- ArriVent BioPharma made up ﹤0.01% of American Century Companies's portfolio in Q2 2026, its #2515 holding.
- American Century Companies first reported a position in ArriVent BioPharma in Q1 2026 and has held it in 2 quarters since.
- 157 funds tracked by Wall St. Rank held ArriVent BioPharma as of Q2 2026.
Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.